Unpacking the Inflation Reduction Act (IRA): Status and Implications Beyond Drug Pricing

Author(s)

Moderator: Jordan M Skiera, PharmD/MSL Candidate of 2025, Samford University McWhorter School of Pharmacy, Birmingham, AL, USA
Speakers: Christoph Glaetzer, Dipl. Kfm, Johnson & Johnson, Princeton, NJ, USA; Joey Mattingly, PharmD, MBA, PhD, Department of Pharmacotherapy, University of Utah College of Pharmacy, Park City, UT, USA; Julie Patterson, PharmD, PhD, National Pharmaceutical Council, Washington, DC, USA; Peter Neumann, ScD, Institute Clinical Research and Health Policy Studies, Tufts University School of Medicine, Boston, MA, USA

The ISPOR Student Network Roundtable Event will discuss the Inflation Reduction Act (IRA), with an overview of the status, next steps, and longer-term implications, as well as a focus on the aspects of the IRA beyond the drug-pricing related components. The talk will explore how the IRA impacts access, affordability and sustainability in health care and implications in healthcare policy decision making.

The talk will be presented by a panel of experts to discuss the IRA from the industry, independent, and academic perspective. The speakers will engage in a discussion both with each other and with the audience through a question-and-answer format. This talk will educate not only students and new professionals, but also all other members of ISPOR attending the conference interested in the impact of the IRA.

Conference/Value in Health Info

2024-05, ISPOR 2024, Atlanta, GA, USA

Code

123

Topic

Health Policy & Regulatory

Explore Related HEOR by Topic

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×